Heterogeneity of Endocrinologic and Metabolic Parameters in Reproductive Age Polycystic Ovary Syndrome (PCOS) Women Concerning the Severity of Hyperandrogenemia—A New Insight on Syndrome Pathogenesis

Autor: Agnieszka Szmyt, Marcin Korman, Katarzyna Ożegowska, Leszek Pawelczyk
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Adult
Hirsutism
medicine.medical_specialty
metabolic disturbances
endocrine system diseases
Health
Toxicology and Mutagenesis

lcsh:Medicine
030209 endocrinology & metabolism
Article
Body Mass Index
Anovulation
hyperandrogenism
Young Adult
03 medical and health sciences
0302 clinical medicine
Insulin resistance
Internal medicine
Follicular phase
medicine
Humans
Testosterone
hirsutism
Dyslipidemias
030219 obstetrics & reproductive medicine
free testosterone
medicine.diagnostic_test
Dehydroepiandrosterone Sulfate
business.industry
Polycystic ovary syndrome (PCOS)
Hyperandrogenism
lcsh:R
Public Health
Environmental and Occupational Health

nutritional and metabolic diseases
Luteinizing Hormone
medicine.disease
Polycystic ovary
female genital diseases and pregnancy complications
Endocrinology
polycystic ovary syndrome
Female
Insulin Resistance
business
Lipid profile
Zdroj: International Journal of Environmental Research and Public Health
Volume 17
Issue 24
International Journal of Environmental Research and Public Health, Vol 17, Iss 9291, p 9291 (2020)
ISSN: 1660-4601
DOI: 10.3390/ijerph17249291
Popis: Background: Polycystic ovary syndrome (PCOS) is characterized by hyperandrogenism, anovulation, infertility, obesity, and insulin resistance, which results in increased concentrations of testosterone (T), which disturbs follicular growth and ovulation. This study aimed to assess PCOS women&rsquo
s clinical, endocrinological, and metabolic parameters concerning hyperandrogenism severity. Results: 314 women (mean age 27.3 ±
4.6
mean body mass index (BMI) 25.7 ±
5.6) with PCOS, were divided into terciles according to T concentrations: <
0.64 ng/mL (group 1), 0.64 to 0.84 ng/mL (Group 2) and >
0.84 ng/mL (group 3). The mean concentration of T in all women was 0.59 ng/mL and correlated negatively with the number of menstrual cycles per year (MPY) (r = &minus
0.36
p <
0.0001) and positively with Ferriman-Gallway score (FG) (r = 0.33
0.0001), luteinizing hormone (LH) (r = 0.19
0.0001) and dehydroepiandrosterone sulfate (DHEAS) (r = 0.52
0.0001). Positive correlation between BMI and hirsutism (r = 0.16
0.0001), total cholesterol (TC) (r = 0.18
0.0001), low-density lipoprotein (LDL) (r = 0.29
0.0001), and triglycerides (TG) (r = 0.40
0.0001) was demonstrated. The division into subgroups confirmed the lowest MPY, highest LH, and hirsutism in group 3. BMI, insulin sensitivity indices, and lipid profile parameters were not different between the three T subgroups. Conclusions: We found no correlation between testosterone levels and insulin sensitivity or dyslipidemia in women with PCOS. Metabolic abnormalities may contribute more significantly than hyperandrogenemia to PCOS development.
Databáze: OpenAIRE